Study questions role of vitamin D in asthma – Reuters


Bioscience Technology

Study questions role of vitamin D in asthma
Reuters
“Our thought was that vitamin D would potentially make . . . the standard therapy, inhaled corticosteroids, work better in these patients, and that it would reduce their asthma exacerbations,” he told Reuters Health. To test that theory, the
Asthma: vitamin D supplements 'do not improve symptoms or treatment'Medical News Today
Vitamin D Flops as Asthma Therapy BoosterMedPage Today
Study Finds Limited Benefit for Vitamin D in Asthma TreatmentBioscience Technology

all 31 news articles »

View full post on asthma – Google News

Study questions role of vitamin D in asthma – Business Insider


Laboratory Equipment

Study questions role of vitamin D in asthma
Business Insider
NEW YORK (Reuters Health) – Giving people with asthma and low vitamin D levels extra doses of the vitamin doesn't do much to help their lungs, a new study suggests. Previous research had linked low vitamin D levels to more asthma-related problems, like …
Asthma: vitamin D supplements 'do not improve symptoms or treatment'Medical News Today
Vitamin D has Little Benefit as Asthma TreatmentLaboratory Equipment
Vitamin D Supplements May Not Help Ease AsthmaHealthDay
Authint Mail
all 27 news articles »

View full post on asthma – Google News

Study Questions Daily Asthma Meds – ABC News (blog)


NBCNews.com (blog)

Study Questions Daily Asthma Meds
ABC News (blog)
Nearly 25 million people in the United States suffer from asthma, and many of them use an inhaled corticosteroid (ICS) medicine two times per day, every day, to prevent asthma symptoms. Unlike albuterol, a medicine that opens the airways and is used
Mild Asthma Patients May Do OK With Less SteroidsWebMD
Can some asthma patients skip the daily inhaler?NBCNews.com (blog)
For Mild Asthma, Daily Steroids May Not Be Needed, Study SaysU.S. News & World Report
MedPage Today –CTV News
all 25 news articles »

View full post on asthma – Google News

Glaxo Tries to Shake Marketing Questions on Advair – Wall Street Journal


Wall Street Journal

Glaxo Tries to Shake Marketing Questions on Advair
Wall Street Journal
GlaxoSmithKline's $3 billion criminal and civil settlement with the U.S. government this week raises questions about the future of asthma treatment Advair.
Glaxo Executives Cited in Case Now Lead Sanofi, ActelionBusinessweek
WSJ: Glaxo Tries to Shake Marketing QuestionsNASDAQ
Ex-Glaxo execs in U.S. case now lead other drugmakersBend Bulletin
FiercePharma –NPR (blog)
all 46 news articles »

View full post on asthma – Google News

Glaxo Tries to Shake Marketing Questions – Wall Street Journal


The Guardian

Glaxo Tries to Shake Marketing Questions
Wall Street Journal
GlaxoSmithKline's $3 billion criminal and civil settlement with the U.S. government this week raises questions about the future of asthma treatment Advair.
Glaxo Executives Cited in Case Now Lead Sanofi, ActelionBusinessweek
WSJ: Glaxo Tries to Shake Marketing QuestionsNASDAQ
Ex-Glaxo execs in U.S. case now lead other drugmakersBend Bulletin
FiercePharma –NPR (blog)
all 46 news articles »

View full post on asthma – Google News